Jinyu Bio-Technology (600201.SH): The genetically engineered subunit vaccine for Clostridium perfringens Type A disease in cattle has obtained a new veterinary drug registration certificate.

Jinyu Bio-Technology (600201.SH) announces that, in accordance with the national regulations "Veterinary Drug Management Regulations" and "Veterinary Drug Registration Measures", the company's wholly-owned subsidiary, Jinyu Baoling Biopharmaceutical Co., Ltd. (hereinafter referred to as "Jinyu Baoling"), in collaboration with other companies, has been approved by the Ministry of Agriculture and Rural Affairs to develop a new veterinary drug, namely the genetically engineered subunit vaccine for Bovine Clostridial Disease (Type A). The "New Veterinary Drug Registration Certificate" has been issued for this product.